MedTrace Logo

Regulation of Inflammatory Genes in Psoriasis

NCT03125655 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2026-04-06

No results posted yet for this study

Summary

Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.

Conditions

Interventions

DIAGNOSTIC_TEST

Inflammatory markers

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-22
Primary Completion
2027-04-10
Completion
2028-04-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03125655 on ClinicalTrials.gov